Received: 15 June 2022
Accepted: 4 December 2022
First Online: 27 December 2022
: The ethics committee (London Queen Square Health Research Authority Research Ethics Committee) of KCL and University of Cambridge gave ethical approval for this work (13/LO/1156). The ethics committee (Radboud Universitair Medisch Centrum Instituut Waarborging Kwaliteit en Veiligheid Commissie Mensgebonden Onderzoek and Regio Arnhem-Nijmegen (Radboud University Medical Centre Institute Ensuring Quality and Safety Committee on Research Involving Human Subjects Arnhem-Nijmegen) of Radboud UMC gave ethical approval of this work (2013/455). The ethics committee of Central Institute of Mannheim (UMM Universitaetsmedizin Mannheim, Medizinische Ethik Commission II (UMM University Medical Mannheim, Medical Ethics Commission II) gave ethical approval for this work (2014-540N-MA). The ethics committee of University of Rome (Universita Campus Bio-Medica De Roma Comitato Etico (University Campus Bio-Medical Ethics Committee De Roma) gave ethical approval of this work (8/14 PAR ComET CBM).
: Not applicable.
: JKB has been a consultant to, advisory board member of, and a speaker for Janssen Cilag BV, Eli Lilly, Shire, Lundbeck, Roche, and Servier. He is not an employee of any of these companies, and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents or royalties. CFB is director and shareholder in SBGNeuro Ltd. The present work is unrelated to the above grants and relationships. TB served in an advisory or consultancy role for ADHS digital, Infectopharm, Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Roche, and Takeda. He received conference support or speaker’s fee by Medice and Takeda. He received royalities from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press. TC has received consultancy from Roche and Servier and received book royalties from Guildford Press and Sage. The other authors report no biomedical financial interests or potential conflicts of interest.